Morphotek, a wholly-owned subsidiary of Eisai, has opened a new pilot manufacturing plant in Exton, Pennsylvania, US, for the production of biological-based therapeutics to help accelerate early-stage clinical trials.
52473
Morphotek opens new manufacturing plant in us
12617
Alchemia to spin off oncology business
110026
Actis Biologics raising USD 500 million for expansion in Malaysia and India
138387
Scientists make breakthrough in plant medicine production
134688
Avesthagen scouting for partners for bioactive ingredients
168298
NEW treatment regime offers hope to cancer patients
157250
Cereplast opens European headquarters in Germany
45833
New York pharmaceutical company to open division this summer
167288
Integrated DNA Technologies celebrates grand opening of European facility
133910
Thermo Fisher Scientific plans for new manufacturing facility in China
87231
Alexion plans to launch eculizumab in Japan
103480
Williams Partners LP starts operations at new plant
115080
Axial Biotech meets major scientific milestones;
59485
Consortium supports next generation drug discovery
120780
China launches experimental module
132591
Mass. biotechnology company relocating to Madison
101808
New advance in ability to target and destroy certain cancer cells